Inside this portfolio
Identified stock classes44
Matched (%)99.61%
| Largest reported stocks | Portfolio weight |
|---|---|
| Eli Lilly & Co | 20.78% |
| Ascendis Pharma A/S | 13.61% |
| Gilead Sciences Inc | 5.10% |
| Rhythm Pharmaceuticals Inc | 4.02% |
| AbbVie Inc | 3.09% |
How to read these numbers
The day the fund recorded its holdings.
The share of the fund’s net assets that we could identify as common-stock classes.